Abstracts: A series of ten 2,4,6-trisubstituted s-triazines was synthesized with benzimidazole, morpholine and different substituted arylamine derivatives. All the products were characterized by conventional and instrumental methods. The compounds were examined for their in vitro microbial activity against gram negative bacteria and gram positive bacteria. Structure of final compound was confirmed by IR, 1 H NMR and mass spectra.
Introduction
Due to the increasing number of multidrug resistant developed by the microbes, Currently used antimicrobial agents are ineffective and antibacterial and antifungal diseases are very common, therefore, the design and synthesis of novel antimicrobial molecules has been of enormous interest in recent years. Literature survey reveals that substituted s-triazine derivatives are associated with a number of pronounced biological activities [1] [2] [3] [4] . The biological activity is a function of physicochemical properties of the targeted molecule and this assessment is based on the kinds of chemicals that might fit into an active site 5, 6 .
During the past few decades, 1,3,5-triazines have been grabbing the attention of the synthetic chemists for their wide gamut of biological activities, such as antimicrobial 7, 8 , antiprotozoal 9 , anticancer 10 , antimalarial 11 and antiviral 12 activity.
All of the s-triazine derivatives that have wide practical application are 2,4,6-mono,di or tri-substituted symmetrical and unsymmetrical compounds bearing different substituents. The most important reagents for obtaining these compounds are cyanuric chloride because of the reactivity of its chlorine atoms towards nucleophiles 13 .
RESEARCH ARTICLE

236
Chem Sci Trans., 2017, 6(2), 235-242
We had synthesized the s-triazinyl derivatives in combination with p-hydroxybenzonitrile and 8-hydroxy quinoline in our previous work we had found that most of the compounds showing good to moderate activity against bacterial species 14 .
Our idea was to combine, benziimidazole, morpholine and s-triazine nucleus, using cyanuric chloride and various amines. As substituted s-triazines derivatives, these compounds remain an attractive proposition, with their significant biological activities. And further incorporation with commercial drug viz. ciprofloxacin, enabling access to a wide array of structures with interesting antimycrobacterial activity.
Experimental
All the chemicals were purchased from Himedia chemical Pvt. Ltd. And melting points were determined using open capillary tubes on electronic apparatus and were uncorrected. The IR spectra (4000-400 cm -1 ) of synthesized compounds were recorded on Shimadzu 8400-s FTIR spectrometer with KBr pellets. To monitor the reactions, establish the identity, purity of reactants and products, thin layer chromatography was performed on TLC coated with silica gel using appropriate mobile phase system and spots were visualized under UV radiation.
Nuclear magnetic resonance spectra was recorded using Bruker 400 MHz model spectrometer using DMSO as a solvent and TMS as internal standard (Chemical shifts in δ ppm). All new compounds were subjected to elemental analysis and the results obtained were in acceptable range.
General Procedure
Synthesis of1- (4,6- 
To a stirred solution of cyanuric chloride (0.1 mol) in acetone (100 mL) at 0-5 o C, the solution of benzimidazole (0.1 mole) in acetone (90 mL) was added drop wise in two hours. During the reaction 10% NaHCO 3 was added to maintain the reaction mixture neutral. The progress of reaction was monitored by TLC using actone: toluene (2:8) as eluent. After the completion of the reaction, the stirring was stopped and the solution was treated with crushed ice. The product obtained was filtered and dried (Scheme 1). The crude product was purified and recrystallization from alcohol. The yield was 85% having melting point 191 o C.
Synthesis of1-[4-chloro-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]-1H benzimidazole(2)
To a stirred solution of 1-(4,6-dichloro-1,3,5-triazin-2-yl)-1H-benzimidazolein acetone at room temperature the solution of morpholine in acetone was slowly added in 2 h the temperature was raised to 45 o C during 2 h. 10% Solution of NaHCO 3 was added to maintain the reaction mixture neutral and further maintained for 2 h. The progress of reaction was monitored by TLC using Acetone : Toulene (2 : 8) after completion of reaction the solution was poured into ice cold water the solid product which was obtained after filtration was dried and recrystallization from absolute alcohol to give the title compound the yield was 75% having melting point 228 o C.
Synthesis of 4-(1H-benzimidazol-1-yl)-N-(4-aryl)-6-(morpholin-4-yl)-1,3,5-triazin-2-amine derivatives(3a-j)
To a solution of 1-[4-chloro-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]-1H-benzimidazole (0.01 mol in 1,4-dioxane 20 mL) appropriate different substituted aryl amines derivatives was added and the reaction mixture was refluxed for 6-10 h. 10% NaHCO 3 was used for neutralization of the reaction mixture after the completion of reaction it was treated with crushed ice and neutralized by dil. HCl the precipitate thus obtained were dried and recrystallization form absolute alcohol. Step-1
Step-2 Step-3
(1) 
Various amines were obtained in 66-83% yield by reacting cyanuric chloride with bezimidazole in first step (Scheme 1) at low temperature and then in second step at room temperature it was reacted with morpholine, in last step at reflux temperature it was reacted with various amine(3a-j). Mass spectral data support the proposed structures. The mass spectrum showed various characteristic peaks. A peak at m/z 388.2 was assigned to the molecular ion. The 1 H NMR spectrums of (5a-j) showed characteristic signals at 7.09 to 7.44 ppm for the aromatic protons. A signal at 9.85 ppm was assigned to the amine proton. A signal at 2.31 ppm was assigned to the methyl proton. The singlet 3.92-3.95 ppm was assigned to the methoxy protons, respectively.
Results and Discussion
The plates are left standings for 1 to 2 hours at room temperature or at 45 o C, as a period of pre-incubation diffusion to minimize the effects of variation in time between the applications of the different solutions. All plates are then incubated for about 18 to 24 hours at the temperature as per bacterial condition. The diameters or areas of the circular inhibition zones produced by standard and test antibiotic solutions are accurately measured. (Figure 2 ). Compound JM-C5 was showed moderate activity as compared to standard one.JM-C1; JM-C3, JM-C9 and JM-C11 were showing poor activity as compare to standard. Activity of synthesized compounds against the gram positive bacteria Bacillus Cereus was found not that active as compared to standard drugs. The most of the compounds were found active at higher concentration. Proteus Mirabilis is a gram negative bacteria used for the antibacterial screening of the synthesized compounds. Compounds JM-C2, JM-C5 and JM-C7 were found poorly active to these bacteria. Other remaining compounds were showing activity at the higher concentration or not active against these bacteria. Activity of synthesized compounds against E. coli (MTCC-600) was found poor most of the compounds were showing poor activity. were obtained in 66-83% yield by reacting cyanuric chloride with bezimidazole in first step at low temperature and then in second step at room temperature it was reacted with morpholine, in last step at reflux temperature it was reacted with various amine(3a-j). Their structures were confirmed by infrared, 1 H-and mass spectrometric analysis. All the synthesized compound were screened against bacterial species the result showed that half of the compound having good activity against bacterial species while remaining compound were showed sowed moderate to poor activity against bacterial and fungal species.
